1. Cerebral and splenic infarctions after injection of N-butyl-2-cyanoacrylate in esophageal variceal bleeding.
- Author
-
Myung DS, Chung CY, Park HC, Kim JS, Cho SB, Lee WS, Choi SK, and Joo YE
- Subjects
- Enbucrilate administration & dosage, Esophageal and Gastric Varices complications, Female, Gastrointestinal Hemorrhage etiology, Humans, Injections, Middle Aged, Cerebral Infarction etiology, Enbucrilate adverse effects, Esophageal and Gastric Varices therapy, Gastrointestinal Hemorrhage therapy, Sclerotherapy adverse effects, Splenic Infarction etiology
- Abstract
Variceal bleeding is the most serious complication of portal hypertension, and it accounts for approximately one fifth to one third of all deaths in liver cirrhosis patients. Currently, endoscopic treatment remains the predominant method for the prevention and treatment of variceal bleeding. Endoscopic treatments include band ligation and injection sclerotherapy. Injection sclerotherapy with N-butyl-2-cyanoacrylate has been successfully used to treat variceal bleeding. Although injection sclerotherapy with N-butyl-2-cyanoacrylate provides effective treatment for variceal bleeding, injection of N-butyl-2-cyanoacrylate is associated with a variety of complications, including systemic embolization. Herein, we report a case of cerebral and splenic infarctions after the injection of N-butyl-2-cyanoacrylate to treat esophageal variceal bleeding.
- Published
- 2013
- Full Text
- View/download PDF